Details of the Drug Combinations

General Information of This Drug (ID: DMNP60F)

Drug Name
Anastrozole   DMNP60F
Synonyms
Anastrazole; Anastrole; Anastrozol; Arimidex; Asiolex; Astra brand of anastrozole; AstraZeneca brand of anastrozole; Zeneca brand of anastrozole; ZD 1033; ZD1033; Zeneca ZD 1033; Arimidex (TN); Arimidex (Zeneca); Arimidex, Anastrozole; ZD-1033; Anastrozole [USAN:INN:BAN]; Anastrozole (JAN/USAN/INN); Alpha,alpha,alpha',alpha'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile; Alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile; 1,3-benzenediacetonitrile, a, a,a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl); 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile); 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile); 2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile); 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Approved [1]
Estrogen-receptor positive breast cancer N.A. Approved [2]
Obesity 5B81 Approved [2]
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1082 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Anastrozole DCH2W42 ABIRATERONE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
ABIRATERONE + Anastrozole DC19U2O ABIRATERONE Astrocytoma (Cell Line: SNB-19) [3]
ABIRATERONE + Anastrozole DCMYPEA ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [3]
ABIRATERONE + Anastrozole DCJFX45 ABIRATERONE Amelanotic melanoma (Cell Line: M14) [4]
ABIRATERONE + Anastrozole DCGZT5P ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
ABIRATERONE + Anastrozole DC9SQBW ABIRATERONE Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Anastrozole + Mechlorethamine DCMJQUH Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Mechlorethamine DCD4O0P Mechlorethamine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Mechlorethamine DCFGI3X Mechlorethamine Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Mechlorethamine DCK36M3 Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Mechlorethamine DCR2GLB Mechlorethamine Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Mechlorethamine DCHRSX5 Mechlorethamine Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Mechlorethamine DCVI2G8 Mechlorethamine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Pentostatin DC53KU2 Pentostatin Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Pentostatin DCW6IWM Pentostatin Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Pentostatin DC98D6N Pentostatin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Pentostatin DC8YF3F Pentostatin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Pentostatin DC9BRGC Pentostatin Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Pentostatin DCUZKXI Pentostatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Picoplatin DCR18FB Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Fulvestrant DC3U3WB Fulvestrant Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Fulvestrant DCE97OY Fulvestrant Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + Fulvestrant DCAGODI Fulvestrant Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Fulvestrant DCY47NH Fulvestrant Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Fulvestrant DCPME5Y Fulvestrant Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Fulvestrant DCRNKSL Fulvestrant Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Fulvestrant DCH5Q1Q Fulvestrant Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Fulvestrant DC7JWCI Fulvestrant Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Fulvestrant DCK23ZR Fulvestrant Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Fulvestrant DCY4UYX Fulvestrant Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Fulvestrant DCULV1D Fulvestrant Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Fulvestrant DC12J0K Fulvestrant Glioma (Cell Line: SF-268) [3]
Anastrozole + Fulvestrant DCZ5EI9 Fulvestrant High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Fulvestrant DCNTOUE Fulvestrant Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Fulvestrant DCJ71DS Fulvestrant Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Fulvestrant DC8R1GL Fulvestrant Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Fulvestrant DCMHSW8 Fulvestrant Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Fulvestrant DCM8N9N Fulvestrant Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Fulvestrant DCAC7FH Fulvestrant Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Fulvestrant DCY4HKY Fulvestrant Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Fulvestrant DCVNJC2 Fulvestrant Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + Ruxolitinib DCCPFYB Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [3]
Anastrozole + Hepzato DCIVBVY Hepzato Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Anastrozole + Hepzato DC4PD82 Hepzato Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Ixabepilone DCOXPS5 Ixabepilone Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Ixabepilone DCUPFA5 Ixabepilone Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Ixabepilone DCBQPJ2 Ixabepilone Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Ixabepilone DCNIHXY Ixabepilone Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Ixabepilone DC1EAFZ Ixabepilone Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Ixabepilone DCFHHEZ Ixabepilone High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Ixabepilone DC1WG6J Ixabepilone High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Ixabepilone DC9364J Ixabepilone Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Ixabepilone DCEMP73 Ixabepilone Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Ixabepilone DC4DR81 Ixabepilone Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Ixabepilone DCY0MOJ Ixabepilone Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Dactinomycin DCERD1A Dactinomycin Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Dactinomycin DCHT8KY Dactinomycin Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + Dactinomycin DCI9SJR Dactinomycin Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Dactinomycin DCXX35R Dactinomycin Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + Dactinomycin DCBVQFF Dactinomycin Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Dactinomycin DC2R9YV Dactinomycin Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Dactinomycin DCZC27R Dactinomycin Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Dactinomycin DC6RPBF Dactinomycin Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Dactinomycin DC2GX7U Dactinomycin Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Dactinomycin DC8AVFE Dactinomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Dactinomycin DCNBZ89 Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Dactinomycin DCHW0LI Dactinomycin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Dactinomycin DCYVK0R Dactinomycin Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Dactinomycin DC42IQJ Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Dactinomycin DCT2QVV Dactinomycin Astrocytoma (Cell Line: U251) [3]
Anastrozole + Dactinomycin DCYWZPX Dactinomycin Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Dactinomycin DCA5LL7 Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Dactinomycin DCB8GD1 Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Dactinomycin DC0WT1V Dactinomycin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Dactinomycin DC87DRU Dactinomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Dactinomycin DCHPZX2 Dactinomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Dactinomycin DCVW2A9 Dactinomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Anastrozole + Dactinomycin DCPAJ4F Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Dactinomycin DCJQ3WP Dactinomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Dactinomycin DCI6ZZ2 Dactinomycin Glioma (Cell Line: SF-539) [3]
Anastrozole + Dactinomycin DCH5Y4R Dactinomycin Glioma (Cell Line: SF-295) [3]
Anastrozole + Dactinomycin DCL7RX4 Dactinomycin Glioma (Cell Line: SF-268) [3]
Anastrozole + Dactinomycin DCKHGX6 Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Dactinomycin DCAN74L Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Dactinomycin DC903VE Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Dactinomycin DC3TRJB Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Dactinomycin DCZOFNI Dactinomycin Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Dactinomycin DC5WR25 Dactinomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Dactinomycin DC7M074 Dactinomycin Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Dactinomycin DCCI0RM Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Dactinomycin DCYB742 Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Dactinomycin DCRQQY4 Dactinomycin Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Dactinomycin DCVSM5U Dactinomycin Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Dactinomycin DCB3PFH Dactinomycin Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Dactinomycin DC748SE Dactinomycin Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Dactinomycin DC31K8Z Dactinomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Dactinomycin DC7CJFL Dactinomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Dactinomycin DCYCAHR Dactinomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Dactinomycin DC723OM Dactinomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Dactinomycin DC3OJL9 Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + Dactinomycin DCLZCCG Dactinomycin Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Dactinomycin DCA9OJ6 Dactinomycin Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Dactinomycin DC7195S Dactinomycin Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + DFN-15 DCDF2FP DFN-15 Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + DFN-15 DCNUK7U DFN-15 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + DFN-15 DC5SZQ9 DFN-15 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + DFN-15 DCPTXDJ DFN-15 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + DFN-15 DCNOG3M DFN-15 Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + DFN-15 DCMY5RP DFN-15 Glioma (Cell Line: SF-268) [3]
Anastrozole + DFN-15 DC610VJ DFN-15 Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + DFN-15 DCP67XG DFN-15 Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Lapatinib DC5NFOY Lapatinib Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Lapatinib DCIPCNR Lapatinib Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Lapatinib DCBFTCX Lapatinib Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Lapatinib DCMEEVM Lapatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Lapatinib DC0U2PK Lapatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Lapatinib DCZFM12 Lapatinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Lapatinib DCKHEPY Lapatinib Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Lapatinib DCDT5GF Lapatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Lapatinib DCPNM6K Lapatinib Glioma (Cell Line: SF-295) [3]
Anastrozole + Lapatinib DCKA679 Lapatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Lapatinib DCPDTOB Lapatinib Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Lapatinib DCTJ047 Lapatinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Lapatinib DCDJOAL Lapatinib Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Lapatinib DCDAL0F Lapatinib Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Lapatinib DCW5339 Lapatinib Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Lapatinib DC098K3 Lapatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Anastrozole + PMID28460551-Compound-2 DCMAH3K PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + PMID28460551-Compound-2 DCSOZ8Y PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + PMID28460551-Compound-2 DCNLFYH PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + PMID28460551-Compound-2 DC9TQKJ PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + PMID28460551-Compound-2 DC9M9EL PMID28460551-Compound-2 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + PMID28460551-Compound-2 DCFMR45 PMID28460551-Compound-2 Glioma (Cell Line: SF-268) [3]
Anastrozole + PMID28460551-Compound-2 DCGCCYS PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + PMID28460551-Compound-2 DC4U7ZX PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + PMID28460551-Compound-2 DCKJW7S PMID28460551-Compound-2 Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + PMID28460551-Compound-2 DC6EVUO PMID28460551-Compound-2 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + PMID28460551-Compound-2 DC1R7FC PMID28460551-Compound-2 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + PMID28460551-Compound-2 DCPJTAO PMID28460551-Compound-2 Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + Crizotinib DC436NK Crizotinib Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Crizotinib DCFNR71 Crizotinib Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Crizotinib DC6FJ4L Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Crizotinib DCNN07Z Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Cyclophosphamide DCRXW7O Cyclophosphamide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + LIAROZOLE DCMUE8J LIAROZOLE Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + LIAROZOLE DCN2T05 LIAROZOLE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + LIAROZOLE DC1ZZEK LIAROZOLE Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + LIAROZOLE DCWVWC2 LIAROZOLE Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + LIAROZOLE DCDM54M LIAROZOLE Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + LIAROZOLE DC7OTZ9 LIAROZOLE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + LIAROZOLE DCURS8Y LIAROZOLE Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + LIAROZOLE DCZK7ME LIAROZOLE Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + LIAROZOLE DC3ZUUG LIAROZOLE Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + LIAROZOLE DCG0XFA LIAROZOLE Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + LIAROZOLE DCE063V LIAROZOLE Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + LIAROZOLE DCL5W1C LIAROZOLE Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Methotrexate DCG1ZJB Methotrexate Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Methotrexate DC9Q7FO Methotrexate Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Methotrexate DCQ8LLF Methotrexate Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Methotrexate DCHRPOO Methotrexate High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Methotrexate DCI2IJG Methotrexate Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Isoniazid DC7UZEJ Isoniazid Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Isoniazid DCEXJK3 Isoniazid Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Isoniazid DCYQBBK Isoniazid Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Isoniazid DCRDS7X Isoniazid Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Isoniazid DCI1VK2 Isoniazid Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Isoniazid DCLR88P Isoniazid Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Anastrozole + Isoniazid DCCMB1S Isoniazid High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Isoniazid DCBBY3T Isoniazid High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Isoniazid DCLH5G2 Isoniazid Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Isoniazid DCYLDPE Isoniazid Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Isoniazid DC5CXHB Isoniazid Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Isoniazid DCWAO3Q Isoniazid Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Isoniazid DCPWRRF Isoniazid Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Isoniazid DCJQUM7 Isoniazid Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Isoniazid DCSKABH Isoniazid Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Arsenic trioxide DCQCPHO Arsenic trioxide Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Vemurafenib DCAZE9H Vemurafenib Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Vemurafenib DCXR3GH Vemurafenib Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + Vemurafenib DCTNCL2 Vemurafenib Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Vemurafenib DCROAA3 Vemurafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Vemurafenib DC69RB4 Vemurafenib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Vemurafenib DCMIKP6 Vemurafenib Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Vemurafenib DCNI8BE Vemurafenib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Plicamycin DCYE4A6 Plicamycin Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Plicamycin DCYXCKT Plicamycin Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Plicamycin DCIYDZ7 Plicamycin Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Plicamycin DCUXZEP Plicamycin Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Plicamycin DC90XQF Plicamycin Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Plicamycin DCYY65A Plicamycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Plicamycin DCZ5850 Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Plicamycin DCGG84H Plicamycin Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Plicamycin DCUUUNL Plicamycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Plicamycin DCQSU79 Plicamycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Plicamycin DCH73NY Plicamycin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Plicamycin DCROOSX Plicamycin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Plicamycin DCX2QXA Plicamycin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Plicamycin DC85V8S Plicamycin Glioblastoma (Cell Line: SNB-75) [3]
Anastrozole + Plicamycin DCF7GQ8 Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Plicamycin DCVNK5E Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Plicamycin DCNNX8T Plicamycin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Plicamycin DCLLGQC Plicamycin Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Plicamycin DC3PUDI Plicamycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Plicamycin DCKOAP8 Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Plicamycin DCGXC2H Plicamycin Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Plicamycin DCD8ZMI Plicamycin Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Plicamycin DCD1H8M Plicamycin Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Plicamycin DCM3WX3 Plicamycin Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Plicamycin DCOI9KK Plicamycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Plicamycin DC0S7IC Plicamycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Plicamycin DC3UO3N Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + Plicamycin DCJNKPH Plicamycin Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Plicamycin DC0Q76N Plicamycin Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Nilotinib DCBYWUK Nilotinib Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Nilotinib DCCEY5Y Nilotinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + Nilotinib DCXFXQT Nilotinib Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Nilotinib DCL1NKJ Nilotinib Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Nilotinib DC64XCV Nilotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Nilotinib DCL25A2 Nilotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Nilotinib DCOXEL1 Nilotinib Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Nilotinib DC1EQVZ Nilotinib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Nilotinib DCDNZM0 Nilotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Nilotinib DCN1HFI Nilotinib Glioma (Cell Line: SF-295) [3]
Anastrozole + Nilotinib DCEQFUQ Nilotinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Nilotinib DCZ54DD Nilotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Nilotinib DC9W2B5 Nilotinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Nilotinib DC943AL Nilotinib Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Nilotinib DCXODC5 Nilotinib Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Nilotinib DCUTPSZ Nilotinib Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Nilotinib DC0TWNA Nilotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Anastrozole + Thioguanine DCVV1GZ Thioguanine Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + Thioguanine DC8XSQU Thioguanine Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Thioguanine DCJHPNU Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Thioguanine DCH9XBO Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Thioguanine DCM1K34 Thioguanine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Thioguanine DC9S8AM Thioguanine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Thioguanine DCX8A0B Thioguanine Glioma (Cell Line: SF-268) [3]
Anastrozole + Thioguanine DC1UERH Thioguanine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Thioguanine DCACI6P Thioguanine Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Thioguanine DCR6Q6T Thioguanine Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Thioguanine DCL9CR5 Thioguanine Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Thioguanine DC8KJ0D Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Thioguanine DC3GEF4 Thioguanine Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Triapine DCU8F7U Triapine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + 10-hydroxycamptothecin DCRFXLO 10-hydroxycamptothecin Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + 10-hydroxycamptothecin DC1WDME 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + 10-hydroxycamptothecin DCUVWOU 10-hydroxycamptothecin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + 10-hydroxycamptothecin DCLTBHM 10-hydroxycamptothecin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Topetecan DC1OHOC Topetecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Topetecan DC62BEA Topetecan Astrocytoma (Cell Line: U251) [3]
Anastrozole + Topetecan DCSER5R Topetecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Amonafide DC4OJYY Amonafide Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Amonafide DCG9A5Z Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Amonafide DCTLVEO Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Amonafide DCK4LYX Amonafide Glioma (Cell Line: SF-268) [3]
Anastrozole + Amonafide DC49VKO Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Amonafide DC2JGFN Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Amonafide DCIIUP3 Amonafide High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Amonafide DC72IMQ Amonafide Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Amonafide DCH8FK5 Amonafide Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Amonafide DC0KYU7 Amonafide Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Amonafide DC5SOBK Amonafide Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Amonafide DCZE5IG Amonafide Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Pralatrexate DC0023Y Pralatrexate Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Pralatrexate DCXVF96 Pralatrexate Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Pralatrexate DCXQAWQ Pralatrexate Glioma (Cell Line: SF-295) [3]
Anastrozole + Pralatrexate DCBP1B4 Pralatrexate High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Pralatrexate DCPRABA Pralatrexate Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Pralatrexate DCJG4Z7 Pralatrexate Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Pralatrexate DCS4OW9 Pralatrexate Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Pralatrexate DCUPT28 Pralatrexate Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Terameprocol DCELYJ3 Terameprocol Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Terameprocol DC7J5TC Terameprocol Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + Terameprocol DCS3R8H Terameprocol Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + Terameprocol DCH2JHS Terameprocol Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Terameprocol DC8Z5CQ Terameprocol Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Terameprocol DCRDJEA Terameprocol Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Terameprocol DCSG078 Terameprocol Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Terameprocol DC8CZ5V Terameprocol Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Terameprocol DCDJK5O Terameprocol Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Terameprocol DC7H6YQ Terameprocol Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Terameprocol DC7P1ER Terameprocol Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Terameprocol DCVFJ86 Terameprocol Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Terameprocol DCFNMNJ Terameprocol High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Terameprocol DC5V9MR Terameprocol Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Terameprocol DCYYHHF Terameprocol Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Terameprocol DCZN753 Terameprocol Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Terameprocol DCHV865 Terameprocol Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Terameprocol DC6F7CB Terameprocol Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Terameprocol DC7ZD9Q Terameprocol Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Terameprocol DC7D92U Terameprocol Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + SCH 727965 DCE7CT4 SCH 727965 Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + SCH 727965 DCU6K9C SCH 727965 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + SCH 727965 DC08EV3 SCH 727965 Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + SCH 727965 DC55ULX SCH 727965 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + SCH 727965 DCW4KX0 SCH 727965 Astrocytoma (Cell Line: U251) [3]
Anastrozole + SCH 727965 DCWOPDO SCH 727965 Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + SCH 727965 DCLHXH9 SCH 727965 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + SCH 727965 DCUCQ4B SCH 727965 Glioma (Cell Line: SF-295) [3]
Anastrozole + SCH 727965 DCGYR7E SCH 727965 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + SCH 727965 DCRKHMP SCH 727965 Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + SCH 727965 DCNX5Z0 SCH 727965 Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + SCH 727965 DCQLL63 SCH 727965 Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + SCH 727965 DCLLGPZ SCH 727965 Melanoma (Cell Line: UACC-257) [3]
Anastrozole + SCH 727965 DC1SI16 SCH 727965 Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Dexrazoxane DCAZ41K Dexrazoxane Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + Dexrazoxane DC4NLZD Dexrazoxane Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Dexrazoxane DCXCEKO Dexrazoxane Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Dexrazoxane DCBEBJD Dexrazoxane Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Dexrazoxane DCXFZFC Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Dexrazoxane DCZ1RMC Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Dexrazoxane DCUOIUK Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Dexrazoxane DCPBQJG Dexrazoxane Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Dexrazoxane DCXDTIC Dexrazoxane Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Dexrazoxane DC6LMTT Dexrazoxane Glioma (Cell Line: SF-539) [3]
Anastrozole + Dexrazoxane DC3IMEK Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Dexrazoxane DCK5U6P Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Dexrazoxane DCN90UU Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Dexrazoxane DCOOP9A Dexrazoxane Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Dexrazoxane DCB2E45 Dexrazoxane Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Dexrazoxane DC76G7Q Dexrazoxane Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Dexrazoxane DCFPXEO Dexrazoxane Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Dexrazoxane DC3U4VG Dexrazoxane Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + Dexrazoxane DCNFXXR Dexrazoxane Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Docetaxel DCORFDL Docetaxel Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Docetaxel DCG507U Docetaxel Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Docetaxel DCC1U6M Docetaxel High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Docetaxel DCHMNE9 Docetaxel Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Docetaxel DCWX9IM Docetaxel Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Docetaxel DC77QMP Docetaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Raloxifene DCYSUA4 Raloxifene Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Raloxifene DCYK3GT Raloxifene Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Raloxifene DC1GG2N Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Raloxifene DC3VLOL Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Raloxifene DC1G579 Raloxifene Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Raloxifene DC34YIL Raloxifene Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Anastrozole + Raloxifene DCQ21UP Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Raloxifene DCX4TRB Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Raloxifene DCT57R0 Raloxifene Glioma (Cell Line: SF-268) [3]
Anastrozole + Raloxifene DC94JEL Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Raloxifene DCIB4LG Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Raloxifene DCGEBHS Raloxifene Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Raloxifene DCJRZMS Raloxifene Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Bendamustine hydrochloride DC15ILZ Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Bendamustine hydrochloride DCPI3WR Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Bendamustine hydrochloride DCQGTDF Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Bendamustine hydrochloride DCX1RMQ Bendamustine hydrochloride Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Bendamustine hydrochloride DC6N1AK Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Bendamustine hydrochloride DCAITIA Bendamustine hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Bendamustine hydrochloride DCRBZ2B Bendamustine hydrochloride Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Bendamustine hydrochloride DCDJ78X Bendamustine hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Bendamustine hydrochloride DCTDZL4 Bendamustine hydrochloride Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Bendamustine hydrochloride DCLNNMV Bendamustine hydrochloride Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Bendamustine hydrochloride DCZYXH8 Bendamustine hydrochloride Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Bendamustine hydrochloride DCHPK19 Bendamustine hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Bendamustine hydrochloride DC6QGB9 Bendamustine hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Bendamustine hydrochloride DC5IV5T Bendamustine hydrochloride High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Bendamustine hydrochloride DCMQD61 Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Bendamustine hydrochloride DCUAJAW Bendamustine hydrochloride Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Bendamustine hydrochloride DCI34T2 Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Bendamustine hydrochloride DCJPU3I Bendamustine hydrochloride Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Bendamustine hydrochloride DCG4XNP Bendamustine hydrochloride Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Bendamustine hydrochloride DC6RAH5 Bendamustine hydrochloride Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Bendamustine hydrochloride DCE8IGO Bendamustine hydrochloride Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Bendamustine hydrochloride DC3HPJB Bendamustine hydrochloride Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Trifluridine DC4AAQ3 Trifluridine Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Trifluridine DCSNXUF Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Trifluridine DCQKJHS Trifluridine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Trifluridine DC498MM Trifluridine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Trifluridine DCI0626 Trifluridine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Trifluridine DCWAO56 Trifluridine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Trifluridine DC8CFQS Trifluridine Glioma (Cell Line: SF-539) [3]
Anastrozole + Trifluridine DCXFRL9 Trifluridine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Trifluridine DCOI2Z2 Trifluridine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Trifluridine DCLL19J Trifluridine Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Trifluridine DCI0L1B Trifluridine Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Trifluridine DC63BSC Trifluridine Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Trifluridine DCONKZC Trifluridine Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Trifluridine DC06727 Trifluridine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Trifluridine DC8XJ9R Trifluridine Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Trifluridine DCTUQZJ Trifluridine Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Sirolimus DCPW5WD Sirolimus Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Sirolimus DCUVMQQ Sirolimus Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Sirolimus DCOIC40 Sirolimus Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Sirolimus DCH0KTB Sirolimus Glioblastoma (Cell Line: SNB-75) [3]
Anastrozole + Sirolimus DCRG1N8 Sirolimus Glioma (Cell Line: SF-268) [3]
Anastrozole + Letrozole DCSUWIH Letrozole Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Letrozole DCN6OLV Letrozole Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Letrozole DCK9491 Letrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Letrozole DCAO6FX Letrozole Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Letrozole DCV1MQP Letrozole Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Letrozole DCZ9WON Letrozole Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Letrozole DC2V2BW Letrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Letrozole DCK7FD5 Letrozole Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Letrozole DCRGZHK Letrozole Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Letrozole DCUQYJ8 Letrozole Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Letrozole DCHQC2J Letrozole Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Letrozole DC4F8EM Letrozole Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Letrozole DCME2NV Letrozole Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Letrozole DC3DAKQ Letrozole Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Letrozole DC2VUPN Letrozole Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Letrozole DCKG4AI Letrozole Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + Letrozole DCTM0KX Letrozole Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Mitomycin DCWH7HC Mitomycin Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Mitomycin DCBXJI6 Mitomycin Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Mitomycin DCCKGCE Mitomycin Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Mitomycin DCZEDZQ Mitomycin Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Mitomycin DCXSS5T Mitomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Mitomycin DC0VBWO Mitomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Mitomycin DCN8360 Mitomycin Astrocytoma (Cell Line: U251) [3]
Anastrozole + Mitomycin DC0TS3E Mitomycin Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Mitomycin DCP9RQP Mitomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Mitomycin DC44FGN Mitomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Mitomycin DCYW5BE Mitomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Mitomycin DCKD7HB Mitomycin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Anastrozole + Mitomycin DC3B7IK Mitomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Mitomycin DC1TYS6 Mitomycin Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Mitomycin DC4ZJTA Mitomycin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Mitomycin DCN22JQ Mitomycin Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Mitomycin DCW17C4 Mitomycin Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Mitomycin DCX8WH2 Mitomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Mitomycin DCW3P9Z Mitomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Mitomycin DCMJT67 Mitomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Anastrozole + Mitomycin DC8OCUC Mitomycin Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Mitomycin DC0EIYD Mitomycin Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + SY-1425 DCZLQU8 SY-1425 Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + SY-1425 DC4XPSN SY-1425 Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + SY-1425 DCQ4I6V SY-1425 Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + SY-1425 DCWHTX7 SY-1425 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + SY-1425 DCT65GT SY-1425 Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + SY-1425 DCZKAZY SY-1425 Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + SY-1425 DCN11GS SY-1425 Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + SY-1425 DC17PO3 SY-1425 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + SY-1425 DCDPON6 SY-1425 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + SY-1425 DC4ZRAJ SY-1425 Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + SY-1425 DCNVP75 SY-1425 Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + SY-1425 DC2NCOS SY-1425 Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + SY-1425 DCNEI8T SY-1425 Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + SY-1425 DCTHLMQ SY-1425 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + SY-1425 DCPG4PL SY-1425 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + Uracil mustard DC3LEMU Uracil mustard Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + Uracil mustard DCVQB8O Uracil mustard Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Uracil mustard DC545GU Uracil mustard Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Uracil mustard DCFQTZU Uracil mustard Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Uracil mustard DCNJL0J Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Uracil mustard DCHW8YW Uracil mustard Astrocytoma (Cell Line: U251) [3]
Anastrozole + Uracil mustard DCZTJRL Uracil mustard Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Uracil mustard DCNSRPB Uracil mustard Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Uracil mustard DCFG5PJ Uracil mustard Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Uracil mustard DCSYQDF Uracil mustard Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Uracil mustard DCNADW8 Uracil mustard Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Uracil mustard DC4HPP3 Uracil mustard Glioma (Cell Line: SF-268) [3]
Anastrozole + Uracil mustard DCDD9JP Uracil mustard Glioma (Cell Line: SF-295) [3]
Anastrozole + Uracil mustard DCIFYW7 Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Uracil mustard DCBK06W Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Uracil mustard DC3K006 Uracil mustard Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Uracil mustard DC2OEW9 Uracil mustard Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Uracil mustard DCMSRPM Uracil mustard Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Uracil mustard DC9232A Uracil mustard Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Uracil mustard DCX9A1W Uracil mustard Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Uracil mustard DCA47NA Uracil mustard Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Uracil mustard DCHZ344 Uracil mustard Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Uracil mustard DCYUYP4 Uracil mustard Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Uracil mustard DCYVQW4 Uracil mustard Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Uracil mustard DCAMKLC Uracil mustard Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Uracil mustard DCTPS00 Uracil mustard Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Uracil mustard DCVJKBU Uracil mustard Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Vincristine DCDE3F9 Vincristine Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Vincristine DC0KO9Y Vincristine Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Vincristine DCUG9B3 Vincristine Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Vincristine DCFZD1N Vincristine Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Vincristine DC9O1VM Vincristine Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Vincristine DC3I1QA Vincristine Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Vincristine DCUWS8K Vincristine Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Vincristine DCCBQ7Y Vincristine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Vincristine DCA8ZI7 Vincristine Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Vincristine DCINFPH Vincristine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Vincristine DCJ9656 Vincristine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Vincristine DCSGKBT Vincristine Glioma (Cell Line: SF-295) [3]
Anastrozole + Vincristine DCMB0CR Vincristine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Vincristine DCET9P5 Vincristine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Vincristine DCGFMQ3 Vincristine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Vincristine DCIFU9Q Vincristine Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Vincristine DC2X725 Vincristine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Vincristine DC5UJ1M Vincristine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Vincristine DCFZP9V Vincristine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Anastrozole + Arfolitixorin DCA6DL5 Arfolitixorin Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Arfolitixorin DCTA4V4 Arfolitixorin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Arfolitixorin DCY7U3V Arfolitixorin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Anastrozole + Arfolitixorin DCSEYWU Arfolitixorin Glioma (Cell Line: SF-268) [3]
Anastrozole + Arfolitixorin DC6KCT3 Arfolitixorin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Arfolitixorin DCDVTZT Arfolitixorin Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Arfolitixorin DCKV4QU Arfolitixorin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Arfolitixorin DC2YA88 Arfolitixorin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Arfolitixorin DCGJN2J Arfolitixorin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Arfolitixorin DCOYMYI Arfolitixorin Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + BIO-300 DCW1MKK BIO-300 Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + BIO-300 DCWD6PD BIO-300 Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + BIO-300 DCHR4L5 BIO-300 Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + BIO-300 DCBDWPI BIO-300 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + BIO-300 DC9XDVA BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + BIO-300 DCXDPNQ BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + BIO-300 DCEQNKL BIO-300 Astrocytoma (Cell Line: U251) [3]
Anastrozole + BIO-300 DC5H0RE BIO-300 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + BIO-300 DCYEZWV BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + BIO-300 DC9V2O1 BIO-300 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + BIO-300 DCNE4OV BIO-300 Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + BIO-300 DC0NMKL BIO-300 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + BIO-300 DC6WDNA BIO-300 Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + BIO-300 DC0F0W4 BIO-300 Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + BIO-300 DCUCYMK BIO-300 Glioma (Cell Line: SF-539) [3]
Anastrozole + BIO-300 DCY41ZS BIO-300 Glioma (Cell Line: SF-295) [3]
Anastrozole + BIO-300 DCNNTFC BIO-300 Glioma (Cell Line: SF-268) [3]
Anastrozole + BIO-300 DC3B8AP BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + BIO-300 DCJCC1H BIO-300 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + BIO-300 DC3524J BIO-300 Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + BIO-300 DC7402G BIO-300 Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + BIO-300 DCHLZYZ BIO-300 Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + BIO-300 DC9XCKG BIO-300 Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + BIO-300 DC7VC4P BIO-300 Melanoma (Cell Line: UACC-257) [3]
Anastrozole + BIO-300 DCDTAMI BIO-300 Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + BIO-300 DCO48KT BIO-300 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + BIO-300 DCZYORF BIO-300 Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + BIO-300 DC1A20Y BIO-300 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + BIO-300 DC0HOY3 BIO-300 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Anastrozole + BIO-300 DC3WP63 BIO-300 Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Altretamine DCCZVGJ Altretamine Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Altretamine DCGDJY6 Altretamine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Altretamine DCUFJS5 Altretamine Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Altretamine DCLF8I1 Altretamine Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Altretamine DC253LQ Altretamine Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Altretamine DC4XEMF Altretamine Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Altretamine DCW57S5 Altretamine Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Altretamine DCK4AZR Altretamine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Altretamine DCK2KAG Altretamine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Altretamine DCV3LP9 Altretamine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + JNK-IN-8 DCDTU3W JNK-IN-8 Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + JNK-IN-8 DC8YFWW JNK-IN-8 Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Idarubicin DCRBX8J Idarubicin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Idarubicin DCOHP4I Idarubicin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Idarubicin DCFNUWN Idarubicin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Idarubicin DCVJSE5 Idarubicin Glioma (Cell Line: SF-268) [3]
Anastrozole + Idarubicin DC7BWI7 Idarubicin Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Imatinib DCSXXU6 Imatinib Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Imatinib DCVNGDA Imatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Imatinib DCSN8I0 Imatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Imatinib DC3ATZK Imatinib Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Imatinib DCSVNE4 Imatinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Imatinib DCNLN84 Imatinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Imatinib DCLY4CC Imatinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Imatinib DCLU836 Imatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Imatinib DCB2979 Imatinib Glioma (Cell Line: SF-295) [3]
Anastrozole + Imatinib DC2Z2Y7 Imatinib Glioma (Cell Line: SF-268) [3]
Anastrozole + Imatinib DCG1TUA Imatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Imatinib DCLKH34 Imatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Imatinib DCBM9NN Imatinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Imatinib DC598OR Imatinib Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Imatinib DCHK93B Imatinib Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Imatinib DC5VZYY Imatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Imatinib DC36EZF Imatinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Anastrozole + Bleomycin DCL07Y4 Bleomycin Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Bleomycin DCJPK9M Bleomycin Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + Bleomycin DCBMWFH Bleomycin Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Bleomycin DCP3S2A Bleomycin Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Bleomycin DC8Y7M4 Bleomycin Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Bleomycin DCA229E Bleomycin Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Bleomycin DCBKWEC Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Bleomycin DC0E2Y1 Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Bleomycin DCLKWT5 Bleomycin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Bleomycin DCGDFI6 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Bleomycin DCGH2PU Bleomycin Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Bleomycin DC36ZL2 Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Bleomycin DC9KFJA Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Bleomycin DCDYXVD Bleomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Bleomycin DCLI8G8 Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Bleomycin DCMR319 Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Bleomycin DCX0LVX Bleomycin Glioblastoma (Cell Line: SNB-75) [3]
Anastrozole + Bleomycin DCJBTUD Bleomycin Glioma (Cell Line: SF-268) [3]
Anastrozole + Bleomycin DC47PXH Bleomycin Glioma (Cell Line: SF-539) [3]
Anastrozole + Bleomycin DCZ98V0 Bleomycin Glioma (Cell Line: SF-295) [3]
Anastrozole + Bleomycin DCYZ7UV Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Bleomycin DC98VLY Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Bleomycin DC6N2AK Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Bleomycin DC1DN9R Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Bleomycin DC68RV7 Bleomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Bleomycin DCNP4GV Bleomycin Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Bleomycin DCACRO0 Bleomycin Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Bleomycin DCKN7LD Bleomycin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Bleomycin DCLRV8D Bleomycin Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Bleomycin DCIB7EA Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Bleomycin DCENW07 Bleomycin Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Bleomycin DCQYOCE Bleomycin Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Bleomycin DC2M1CK Bleomycin Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Bleomycin DC4ZJ08 Bleomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Bleomycin DCWQ6AD Bleomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Bleomycin DC1WGMM Bleomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Bleomycin DCY21HT Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Bleomycin DCUPAPJ Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + Bleomycin DCTJ00V Bleomycin Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Bleomycin DCULZVW Bleomycin Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + Bortezomib DCM9YOR Bortezomib Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Bortezomib DCIJJT0 Bortezomib Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Bortezomib DCJMQTO Bortezomib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Bortezomib DCLUUJ5 Bortezomib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Bortezomib DCWX6KG Bortezomib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Bortezomib DC8BFXL Bortezomib Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Bortezomib DC9HNXQ Bortezomib Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Bortezomib DCFY4TL Bortezomib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Dacarbazine DC90POZ Dacarbazine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Dacarbazine DC75U61 Dacarbazine Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Dacarbazine DCCX41M Dacarbazine Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Dacarbazine DCHGAXW Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Dacarbazine DCVZMEB Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Dacarbazine DC6FU5V Dacarbazine Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Dacarbazine DCBI9HN Dacarbazine Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Dacarbazine DCBWC5Y Dacarbazine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Dacarbazine DCAJZQ5 Dacarbazine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Dacarbazine DCLPLRW Dacarbazine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Dacarbazine DC06M8J Dacarbazine Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Dacarbazine DC1LQBA Dacarbazine Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Valrubicin DCR9XFM Valrubicin Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Valrubicin DC60X52 Valrubicin Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Valrubicin DC6LPXE Valrubicin Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Valrubicin DC604E6 Valrubicin Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Valrubicin DCX806B Valrubicin Glioblastoma (Cell Line: SNB-75) [3]
Anastrozole + Valrubicin DCIYL3M Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Valrubicin DC2L1WV Valrubicin Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Valrubicin DCV02YK Valrubicin Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Valrubicin DC6D41S Valrubicin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Valrubicin DC54G2J Valrubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Topotecan DCF18LA Topotecan Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + Topotecan DCPCEKO Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Topotecan DCOA4AS Topotecan Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Topotecan DC5G0RH Topotecan Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Topotecan DCDFIKF Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Topotecan DCMMNUP Topotecan Glioblastoma (Cell Line: SNB-75) [3]
Anastrozole + Topotecan DCJACL5 Topotecan Glioma (Cell Line: SF-268) [3]
Anastrozole + Topotecan DC6Q7NE Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Topotecan DCHSSPI Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Topotecan DC4S9BS Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Topotecan DCMM2B4 Topotecan Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Topotecan DCI6WN6 Topotecan Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Topotecan DCHU5QO Topotecan Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Topotecan DCTNAGA Topotecan Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Topotecan DCWPWW3 Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Topotecan DCFB4IJ Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Topotecan DC2DFV4 Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Topotecan DCH7W0W Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Topotecan DC6GXEZ Topotecan Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Topotecan DCMMPEX Topotecan Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + Cisplatin DCBAIG1 Cisplatin Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Cisplatin DCG41Y7 Cisplatin Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Cisplatin DCZOZWD Cisplatin Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Cisplatin DCRXAEX Cisplatin Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Cisplatin DCTLDDS Cisplatin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Cisplatin DC0554K Cisplatin Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Cisplatin DC07872 Cisplatin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Cisplatin DCSWBNP Cisplatin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Cisplatin DCXERDL Cisplatin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Cisplatin DC6DE0Z Cisplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Cisplatin DCQLHAN Cisplatin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Cisplatin DCA7CID Cisplatin Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Cisplatin DC5C7XA Cisplatin Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + Cisplatin DCXDNMD Cisplatin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Cisplatin DCB3TOC Cisplatin Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Cisplatin DC7ZEQN Cisplatin Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Cisplatin DCNQ9UY Cisplatin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Cisplatin DC3PWCD Cisplatin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Chlorambucil DCE00J5 Chlorambucil Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Chlorambucil DCLTU15 Chlorambucil Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Chlorambucil DC1IS9I Chlorambucil Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Chlorambucil DCJPDRC Chlorambucil High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Chlorambucil DCAV8GE Chlorambucil Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Chlorambucil DCD5OY8 Chlorambucil Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Chlorambucil DC1B840 Chlorambucil Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Chlorambucil DCU0DS0 Chlorambucil Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Chlorambucil DC87KTP Chlorambucil Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Sorafenib DC1959K Sorafenib Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Sorafenib DCGIS25 Sorafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Sorafenib DCG4001 Sorafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Sorafenib DCLMTEF Sorafenib Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Sorafenib DCRCH6Z Sorafenib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + ER819762 DCJDF75 ER819762 Adenocarcinoma (Cell Line: OVCAR3) [3]
Anastrozole + ER819762 DC8VAV9 ER819762 Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + ER819762 DCUB61R ER819762 Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + ER819762 DC90OOZ ER819762 Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + ER819762 DCVHZ1T ER819762 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + ER819762 DCQKV2N ER819762 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + ER819762 DCOA0S0 ER819762 Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + ER819762 DCQUGZE ER819762 Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + ER819762 DC4N68Y ER819762 Astrocytoma (Cell Line: U251) [3]
Anastrozole + ER819762 DCR8CX4 ER819762 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + ER819762 DCSWWTU ER819762 Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + ER819762 DC4GOQ4 ER819762 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + ER819762 DC6DNWM ER819762 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + ER819762 DCI8B6Z ER819762 Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + ER819762 DCIX5UB ER819762 Glioma (Cell Line: SF-268) [3]
Anastrozole + ER819762 DC870JH ER819762 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + ER819762 DC9ELII ER819762 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + ER819762 DC9FC9C ER819762 Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + ER819762 DCZPCKS ER819762 Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + ER819762 DC9UTZ7 ER819762 Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + ER819762 DCWILOG ER819762 Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + ER819762 DCQW4AN ER819762 Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + ER819762 DC9C17K ER819762 Melanoma (Cell Line: UACC-257) [3]
Anastrozole + ER819762 DCKUALD ER819762 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + ER819762 DCDGR3U ER819762 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + ER819762 DCP65TF ER819762 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + ER819762 DCDSU89 ER819762 Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + ER819762 DCIP2HI ER819762 Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + ER819762 DC1ID42 ER819762 Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Romidepsin DCUV14I Romidepsin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Romidepsin DCPKFO1 Romidepsin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Anastrozole + Romidepsin DCX20P7 Romidepsin Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Romidepsin DC3KSM8 Romidepsin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Romidepsin DCK1WCH Romidepsin Glioma (Cell Line: SF-295) [3]
Anastrozole + Romidepsin DCUCTAF Romidepsin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Romidepsin DC4RM5R Romidepsin Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Anastrozole + Romidepsin DCY7FBF Romidepsin Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Romidepsin DCHS7ZE Romidepsin Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Romidepsin DCOD6KC Romidepsin Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Romidepsin DC6OPB7 Romidepsin Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Romidepsin DCDMINM Romidepsin Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Romidepsin DC9IGYM Romidepsin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Romidepsin DCE5YJ2 Romidepsin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Romidepsin DCWLL2V Romidepsin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Anastrozole + Romidepsin DCV34F4 Romidepsin Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Romidepsin DCHNQ51 Romidepsin Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Azacitidine DCMNJEJ Azacitidine Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Azacitidine DC7RMWV Azacitidine Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Azacitidine DCZDQQB Azacitidine Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Azacitidine DCLTZ89 Azacitidine Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Azacitidine DCONU71 Azacitidine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Azacitidine DC7SQPL Azacitidine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Azacitidine DC5TPRB Azacitidine Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Azacitidine DCA5N55 Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Azacitidine DC75XKT Azacitidine Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Azacitidine DCWSKM9 Azacitidine Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Azacitidine DCY2VTA Azacitidine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Azacitidine DCQQGCV Azacitidine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Azacitidine DC1V1AW Azacitidine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Azacitidine DCHCHJK Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + Pomalidomide DCPO570 Pomalidomide Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + Pomalidomide DCUCWCT Pomalidomide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Pomalidomide DC44B5Z Pomalidomide Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Pomalidomide DC7L87U Pomalidomide Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Pomalidomide DCDFF63 Pomalidomide Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Pomalidomide DCW6G7W Pomalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Anastrozole + Pomalidomide DCOBHUC Pomalidomide Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Pomalidomide DCLP0TM Pomalidomide Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + Vinflunine DCDP90O Vinflunine Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + Vinflunine DCJBSUM Vinflunine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Vinflunine DCM6V34 Vinflunine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Vinflunine DC0SDLW Vinflunine Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Mercaptopurine DCYDNS8 Mercaptopurine Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Mercaptopurine DCLEURE Mercaptopurine Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Mercaptopurine DCUNF41 Mercaptopurine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Mercaptopurine DCQFN5O Mercaptopurine Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Mercaptopurine DCJHLG9 Mercaptopurine Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Mercaptopurine DCGPJ9J Mercaptopurine Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Mercaptopurine DCJ4T9R Mercaptopurine Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Mercaptopurine DC2FREV Mercaptopurine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Mercaptopurine DCL5SVN Mercaptopurine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Mercaptopurine DC0QMDX Mercaptopurine Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Mepacrine DC9RABQ Mepacrine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Mepacrine DC1A6JX Mepacrine Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Mepacrine DCPGUWF Mepacrine Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Mepacrine DC9VIY0 Mepacrine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Mepacrine DCNUJMX Mepacrine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Mepacrine DC9LK0W Mepacrine Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Mepacrine DCWLIE6 Mepacrine Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Taxol DC3OQNA Taxol Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + Taxol DC2IHHF Taxol High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Fludarabine DC3PNQ6 Fludarabine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Fludarabine DCOX56R Fludarabine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Fludarabine DCDMWQX Fludarabine Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Fludarabine DC1IQXN Fludarabine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Fludarabine DCIFRDC Fludarabine Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Fludarabine DCJYH93 Fludarabine Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Fludarabine DCSU1GS Fludarabine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Fludarabine DCIUSUD Fludarabine Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + PMID28870136-Compound-43 DCOWEUA PMID28870136-Compound-43 Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + PMID28870136-Compound-43 DCWRDFL PMID28870136-Compound-43 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + PMID28870136-Compound-43 DCJXSUI PMID28870136-Compound-43 Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + PMID28870136-Compound-43 DCOTP9S PMID28870136-Compound-43 Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + PMID28870136-Compound-43 DCPZNOC PMID28870136-Compound-43 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + PMID28870136-Compound-43 DCV9CNN PMID28870136-Compound-43 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + PMID28870136-Compound-43 DC45NA7 PMID28870136-Compound-43 Lung adenocarcinoma (Cell Line: HOP-62) [3]
Anastrozole + PMID28870136-Compound-43 DCMIG24 PMID28870136-Compound-43 Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + FORMESTANE DCNIT92 FORMESTANE Adenocarcinoma (Cell Line: SW-620) [3]
Anastrozole + FORMESTANE DCGAMLA FORMESTANE Adenocarcinoma (Cell Line: HCT-15) [3]
Anastrozole + FORMESTANE DCMGUX2 FORMESTANE Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + FORMESTANE DC7KDPM FORMESTANE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + FORMESTANE DC3B40U FORMESTANE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + FORMESTANE DCGINAD FORMESTANE Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + FORMESTANE DC4AAGR FORMESTANE Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + FORMESTANE DC41T82 FORMESTANE Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + FORMESTANE DC8ZQ0N FORMESTANE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Anastrozole + FORMESTANE DCL4RZY FORMESTANE Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + FORMESTANE DCIUPEX FORMESTANE Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + FORMESTANE DCC1U82 FORMESTANE Melanoma (Cell Line: UACC-257) [3]
Anastrozole + FORMESTANE DC6I9H3 FORMESTANE Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + FORMESTANE DC4HGYB FORMESTANE Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + FORMESTANE DCK7IB0 FORMESTANE Renal cell carcinoma (Cell Line: SN12C) [3]
Anastrozole + Aminolevulinic Acid Hydrochloride DC83HRV Aminolevulinic Acid Hydrochloride Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Aminolevulinic Acid Hydrochloride DCQTZ1J Aminolevulinic Acid Hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Aminolevulinic Acid Hydrochloride DCJ042Z Aminolevulinic Acid Hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Aminolevulinic Acid Hydrochloride DCQ79CS Aminolevulinic Acid Hydrochloride Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Estramustine DCO9RPD Estramustine Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Estramustine DCPEYB2 Estramustine Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Estramustine DC36V36 Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Estramustine DCU5RSH Estramustine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Estramustine DC76UBD Estramustine Glioblastoma (Cell Line: SNB-75) [3]
Anastrozole + Estramustine DCLTAJ9 Estramustine Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Estramustine DCCN5GI Estramustine Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Estramustine DCWBHKI Estramustine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Digitoxin DCYH82Y Digitoxin Adenocarcinoma (Cell Line: DU-145) [3]
Anastrozole + Digitoxin DCZ76CW Digitoxin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Anastrozole + Digitoxin DC1OGW8 Digitoxin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Digitoxin DCZ2SH5 Digitoxin Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Digitoxin DCBLDDE Digitoxin Glioma (Cell Line: SF-268) [3]
Anastrozole + Digitoxin DC2WRDX Digitoxin Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Digitoxin DC3K4Y3 Digitoxin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Anastrozole + Digitoxin DCHK22O Digitoxin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Digitoxin DCNMBQF Digitoxin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Busulfan DC3IK7W Busulfan Adenocarcinoma (Cell Line: HT29) [3]
Anastrozole + Busulfan DCDMPBB Busulfan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Busulfan DCHW3E5 Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Busulfan DC7XZ3A Busulfan Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Busulfan DC5ZSWM Busulfan Clear cell renal cell carcinoma (Cell Line: A498) [3]
Anastrozole + Busulfan DC4RHSZ Busulfan Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Busulfan DCVGKR5 Busulfan Glioma (Cell Line: SF-539) [3]
Anastrozole + Busulfan DCXN383 Busulfan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Busulfan DCOS7TZ Busulfan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Busulfan DCV0OB8 Busulfan Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Anastrozole + Dasatinib DCDVARM Dasatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Dasatinib DCZ9ZDW Dasatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Anastrozole + Dasatinib DCRN6RH Dasatinib Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Mechlorethamine DCYXHU9 Mechlorethamine Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Pentostatin DCLQ2AB Pentostatin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Ixabepilone DCYGQ3V Ixabepilone Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Dactinomycin DCJA5N1 Dactinomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Dactinomycin DCHI90F Dactinomycin Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Dactinomycin DCF7EU5 Dactinomycin Carcinoma (Cell Line: MCF7) [5]
Anastrozole + Dactinomycin DCEFNPL Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Dactinomycin DCZESJD Dactinomycin Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Dactinomycin DCKXSIF Dactinomycin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Dactinomycin DCZSLQP Dactinomycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Lapatinib DCEZJFV Lapatinib Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Lapatinib DC4PXPN Lapatinib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + PMID28460551-Compound-2 DC3TC7I PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + PMID28460551-Compound-2 DCCU331 PMID28460551-Compound-2 Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + PMID28460551-Compound-2 DC82ESU PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Crizotinib DCXZ8IB Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + LIAROZOLE DCNXHSD LIAROZOLE Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Methotrexate DCJOBPG Methotrexate Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Isoniazid DC37Q4X Isoniazid Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Isoniazid DC6V0KB Isoniazid Carcinoma (Cell Line: MCF7) [5]
Anastrozole + Isoniazid DCYX8AP Isoniazid Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Isoniazid DC4KJ9Z Isoniazid Invasive ductal carcinoma (Cell Line: T-47D) [5]
Anastrozole + Isoniazid DC0T6OY Isoniazid Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Isoniazid DCNCBGY Isoniazid Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Plicamycin DC0L9MR Plicamycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Plicamycin DC2PVBM Plicamycin Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Plicamycin DC6HWDC Plicamycin Carcinoma (Cell Line: MCF7) [5]
Anastrozole + Plicamycin DC2OUMY Plicamycin Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Plicamycin DCKXCM0 Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Plicamycin DCK29HU Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Nilotinib DCMX5WL Nilotinib Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Thioguanine DC56UWD Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Thioguanine DCU1GZQ Thioguanine Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Thioguanine DCOSP9K Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Thioguanine DCPD4AD Thioguanine Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Triapine DCZIUTK Triapine Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Topetecan DCGPV2K Topetecan Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Amonafide DCNAKNX Amonafide Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Amonafide DC1ECGU Amonafide Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Amonafide DC8NUM7 Amonafide Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Terameprocol DC91VOU Terameprocol Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Terameprocol DCN7U0E Terameprocol Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Terameprocol DCO56FK Terameprocol Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Terameprocol DCL0260 Terameprocol Invasive ductal carcinoma (Cell Line: T-47D) [5]
Anastrozole + Terameprocol DCC53BO Terameprocol Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + SCH 727965 DC7CE7O SCH 727965 Carcinoma (Cell Line: MCF7) [5]
Anastrozole + SCH 727965 DCF6OE9 SCH 727965 Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Dexrazoxane DCYMOIL Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Dexrazoxane DCF720F Dexrazoxane Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Dexrazoxane DCNPD7L Dexrazoxane Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Raloxifene DCD77U9 Raloxifene Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Raloxifene DCY7NWZ Raloxifene Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Bendamustine hydrochloride DCV9UA7 Bendamustine hydrochloride Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Bendamustine hydrochloride DCI4LEC Bendamustine hydrochloride Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Bendamustine hydrochloride DCPMULY Bendamustine hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Trifluridine DCM74A9 Trifluridine Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Trifluridine DCK29XP Trifluridine Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Trifluridine DC6SD5V Trifluridine Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Letrozole DCSAWVU Letrozole Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Letrozole DCRQ8KL Letrozole Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Letrozole DC8XM9G Letrozole Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Mitomycin DCG086K Mitomycin Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Mitomycin DCG8NEH Mitomycin Carcinoma (Cell Line: MCF7) [5]
Anastrozole + Mitomycin DCTLEKO Mitomycin Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Mitomycin DCEZDER Mitomycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Mitomycin DCKBAXG Mitomycin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Uracil mustard DC90XBP Uracil mustard Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Uracil mustard DC7NM1L Uracil mustard Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Uracil mustard DC31EML Uracil mustard Invasive ductal carcinoma (Cell Line: T-47D) [5]
Anastrozole + Vincristine DCKEV60 Vincristine Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Arfolitixorin DC4J5QL Arfolitixorin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Arfolitixorin DCZ9UE2 Arfolitixorin Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Arfolitixorin DC0E1I4 Arfolitixorin Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Arfolitixorin DCWRPWF Arfolitixorin Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + BIO-300 DCRXEXJ BIO-300 Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + BIO-300 DC591OB BIO-300 Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + BIO-300 DCSLGFL BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + BIO-300 DCDI826 BIO-300 Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + BIO-300 DCT6OP4 BIO-300 Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Altretamine DCVMBWZ Altretamine Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Idarubicin DCGXZRL Idarubicin Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Idarubicin DCFEB0X Idarubicin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Imatinib DCOC6TY Imatinib Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Bleomycin DCKWBA8 Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Bleomycin DC63HP7 Bleomycin Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + Bleomycin DCGVFDE Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Bleomycin DC8RNNV Bleomycin Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Bleomycin DCVRVC5 Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Bortezomib DCLDR8U Bortezomib Carcinoma (Cell Line: MCF7) [5]
Anastrozole + Valrubicin DCFYXDI Valrubicin Colon carcinoma (Cell Line: KM12) [5]
Anastrozole + Valrubicin DCWCHDV Valrubicin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Topotecan DCLK1FS Topotecan Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + Topotecan DCG08CI Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Cisplatin DCDPH1B Cisplatin Carcinoma (Cell Line: MCF7) [5]
Anastrozole + Cisplatin DCFTDY3 Cisplatin Invasive ductal carcinoma (Cell Line: T-47D) [5]
Anastrozole + Cisplatin DC9CYNU Cisplatin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Cisplatin DCKA27G Cisplatin Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Chlorambucil DC8FQCO Chlorambucil Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Sorafenib DC7BGM5 Sorafenib Carcinoma (Cell Line: RXF 393) [5]
Anastrozole + ER819762 DCK1RKY ER819762 Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Anastrozole + ER819762 DCF8X2J ER819762 Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + ER819762 DCRTR6D ER819762 Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + ER819762 DCU6OLM ER819762 Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Romidepsin DCS672W Romidepsin Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Azacitidine DCEIOY4 Azacitidine Invasive ductal carcinoma (Cell Line: T-47D) [5]
Anastrozole + Azacitidine DC17HBZ Azacitidine Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Pomalidomide DC4ABE3 Pomalidomide Carcinoma (Cell Line: MCF7) [5]
Anastrozole + Pomalidomide DCOM3MI Pomalidomide Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Pomalidomide DC8KVYX Pomalidomide Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Pomalidomide DC8QLUO Pomalidomide Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Pomalidomide DC5TSQG Pomalidomide Invasive ductal carcinoma (Cell Line: T-47D) [5]
Anastrozole + Vinflunine DC0XG9P Vinflunine Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + Mercaptopurine DCKHSF7 Mercaptopurine Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Taxol DC0BGVB Taxol Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Fludarabine DC7E5SE Fludarabine Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Fludarabine DCDGCSY Fludarabine Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Anastrozole + FORMESTANE DCWW216 FORMESTANE Invasive ductal carcinoma (Cell Line: T-47D) [5]
Anastrozole + Aminolevulinic Acid Hydrochloride DC0I3JT Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [5]
Anastrozole + Digitoxin DCEOTIC Digitoxin Carcinoma (Cell Line: MCF7) [5]
Anastrozole + Busulfan DCG3WI5 Busulfan Colon adenocarcinoma (Cell Line: COLO 205) [5]
Anastrozole + Dasatinib DCXCXRO Dasatinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Cabazitaxel + Anastrozole DC7SNW1 Cabazitaxel Adenocarcinoma (Cell Line: DU-145) [3]
Cabazitaxel + Anastrozole DCDDIOA Cabazitaxel Adenocarcinoma (Cell Line: A549) [3]
Cabazitaxel + Anastrozole DCCDYCA Cabazitaxel Adenocarcinoma (Cell Line: HCC-2998) [3]
Cabazitaxel + Anastrozole DCS7ILA Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [3]
Cabazitaxel + Anastrozole DCTVF9E Cabazitaxel Adenocarcinoma (Cell Line: HCT116) [3]
Cabazitaxel + Anastrozole DC7AE5Q Cabazitaxel Adenocarcinoma (Cell Line: HT29) [3]
Cabazitaxel + Anastrozole DCIV2GJ Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Cabazitaxel + Anastrozole DCTLWBC Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Cabazitaxel + Anastrozole DCWFOHV Cabazitaxel Astrocytoma (Cell Line: SNB-19) [3]
Cabazitaxel + Anastrozole DC5UWSG Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Cabazitaxel + Anastrozole DCADGPM Cabazitaxel Clear cell renal cell carcinoma (Cell Line: A498) [3]
Cabazitaxel + Anastrozole DC2WNIY Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Cabazitaxel + Anastrozole DCDIB54 Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Cabazitaxel + Anastrozole DC7XU6O Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Cabazitaxel + Anastrozole DCLQMQB Cabazitaxel Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Cabazitaxel + Anastrozole DC3ERWU Cabazitaxel Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Cabazitaxel + Anastrozole DCM4ZUU Cabazitaxel Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Cabazitaxel + Anastrozole DCUFCJQ Cabazitaxel Prostate carcinoma (Cell Line: PC-3) [3]
Cabazitaxel + Anastrozole DCMZAP2 Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [3]
Cabazitaxel + Anastrozole DCU4J9G Cabazitaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Cabazitaxel + Anastrozole DCK9WX7 Cabazitaxel Carcinoma (Cell Line: RXF 393) [5]
Cabazitaxel + Anastrozole DC095CB Cabazitaxel Colon carcinoma (Cell Line: KM12) [5]
Cabazitaxel + Anastrozole DC2BU7V Cabazitaxel Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Crizotinib + Anastrozole DC70EOU Crizotinib Adenocarcinoma (Cell Line: DU-145) [3]
Crizotinib + Anastrozole DC9P94G Crizotinib Adenocarcinoma (Cell Line: HCT-15) [3]
Crizotinib + Anastrozole DC7NGLJ Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Crizotinib + Anastrozole DC7XM1F Crizotinib Amelanotic melanoma (Cell Line: M14) [3]
Crizotinib + Anastrozole DCOQN9P Crizotinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Crizotinib + Anastrozole DC8Y4HY Crizotinib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Crizotinib + Anastrozole DCM9KEF Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Crizotinib + Anastrozole DCG3FXC Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Crizotinib + Anastrozole DC3HEKF Crizotinib Lung adenocarcinoma (Cell Line: HOP-62) [3]
Crizotinib + Anastrozole DCGD65T Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Crizotinib + Anastrozole DCX70FT Crizotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Crizotinib + Anastrozole DC8ZGFV Crizotinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Crizotinib + Anastrozole DCY9LYC Crizotinib Prostate carcinoma (Cell Line: PC-3) [3]
Crizotinib + Anastrozole DC6R58Y Crizotinib Renal cell carcinoma (Cell Line: UO-31) [3]
Crizotinib + Anastrozole DCN38FX Crizotinib Renal cell carcinoma (Cell Line: SN12C) [3]
Crizotinib + Anastrozole DCBTJIR Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Crizotinib + Anastrozole DCMHV8H Crizotinib Colon carcinoma (Cell Line: KM12) [5]
Crizotinib + Anastrozole DC60WHV Crizotinib Invasive ductal carcinoma (Cell Line: HS 578T) [5]
Epirubicin + Anastrozole DC9HD8S Epirubicin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Epirubicin + Anastrozole DCINRQ2 Epirubicin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Epirubicin + Anastrozole DCB27HE Epirubicin Renal cell carcinoma (Cell Line: SN12C) [3]
Epirubicin + Anastrozole DC8SIII Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Epirubicin + Anastrozole DCZU0NJ Epirubicin Lung adenocarcinoma (Cell Line: HOP-62) [4]
Epirubicin + Anastrozole DC413VI Epirubicin Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Epirubicin + Anastrozole DC6FVQG Epirubicin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Gefitinib + Anastrozole DC31UBG Gefitinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Gefitinib + Anastrozole DCFRGJ3 Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Gefitinib + Anastrozole DCNCFW6 Gefitinib Glioma (Cell Line: SF-295) [3]
Gefitinib + Anastrozole DC5ODO0 Gefitinib Glioma (Cell Line: SF-268) [3]
Gefitinib + Anastrozole DC6WTY6 Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Gefitinib + Anastrozole DCXR1QY Gefitinib Lung adenocarcinoma (Cell Line: EKVX) [3]
Gefitinib + Anastrozole DC0C47R Gefitinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Gefitinib + Anastrozole DCNO6NE Gefitinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Gefitinib + Anastrozole DC05NSZ Gefitinib Melanoma (Cell Line: UACC-257) [3]
Gefitinib + Anastrozole DCXZ73Z Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Gefitinib + Anastrozole DC270YW Gefitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Gefitinib + Anastrozole DCISCHY Gefitinib Prostate carcinoma (Cell Line: PC-3) [3]
Gefitinib + Anastrozole DCQWPKJ Gefitinib Renal cell carcinoma (Cell Line: UO-31) [3]
Gefitinib + Anastrozole DCYBCDH Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Gefitinib + Anastrozole DCQ7SCS Gefitinib Colon carcinoma (Cell Line: KM12) [5]
Indazole derivative 5 + Anastrozole DCHKL29 Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Indazole derivative 5 + Anastrozole DCHGU51 Indazole derivative 5 Renal cell carcinoma (Cell Line: UO-31) [3]
Indazole derivative 5 + Anastrozole DC8YIWZ Indazole derivative 5 Renal cell carcinoma (Cell Line: SN12C) [3]
Indazole derivative 5 + Anastrozole DCQIN1C Indazole derivative 5 Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Indazole derivative 5 + Anastrozole DCI14W2 Indazole derivative 5 Amelanotic melanoma (Cell Line: M14) [4]
Indazole derivative 5 + Anastrozole DCIGAQL Indazole derivative 5 Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Indazole derivative 5 + Anastrozole DCIKO8B Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [4]
Indazole derivative 5 + Anastrozole DCMF5PD Indazole derivative 5 Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Indazole derivative 5 + Anastrozole DCIR1Q5 Indazole derivative 5 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Lenalidomide + Anastrozole DC0UG5H Lenalidomide Clear cell renal cell carcinoma (Cell Line: A498) [3]
Lenalidomide + Anastrozole DCGLJE1 Lenalidomide Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Lenalidomide + Anastrozole DC6VD9E Lenalidomide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Lenalidomide + Anastrozole DCXWW4B Lenalidomide Renal cell carcinoma (Cell Line: UO-31) [3]
Lenalidomide + Anastrozole DC3NAN2 Lenalidomide Colon adenocarcinoma (Cell Line: COLO 205) [5]
Lenalidomide + Anastrozole DCPVG7R Lenalidomide Invasive ductal carcinoma (Cell Line: BT-549) [5]
Lenalidomide + Anastrozole DCHASPZ Lenalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [4]
Lenalidomide + Anastrozole DCRSPQM Lenalidomide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [4]
Lenalidomide + Anastrozole DC1VYMY Lenalidomide Lung adenocarcinoma (Cell Line: NCI-H522) [4]
Lenalidomide + Anastrozole DCS2PAQ Lenalidomide Malignant melanoma (Cell Line: LOX IMVI) [4]
Lenalidomide + Anastrozole DC5L3L7 Lenalidomide Malignant melanoma (Cell Line: UACC62) [4]
Lenalidomide + Anastrozole DCGTLFM Lenalidomide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [4]
Lenalidomide + Anastrozole DCGJQN1 Lenalidomide Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Lenalidomide + Anastrozole DC12DLB Lenalidomide Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Lenalidomide + Anastrozole DCQWWC5 Lenalidomide Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Lenalidomide + Anastrozole DCPW71W Lenalidomide Prostate carcinoma (Cell Line: PC-3) [4]
Raloxifene + Anastrozole DC4IHSO Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Raloxifene + Anastrozole DC2DGBT Raloxifene Anaplastic large cell lymphoma (Cell Line: SR) [3]
Raloxifene + Anastrozole DC1IPYH Raloxifene Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Raloxifene + Anastrozole DC0MM99 Raloxifene Invasive ductal carcinoma (Cell Line: BT-549) [5]
Raloxifene + Anastrozole DC7L29B Raloxifene Adenocarcinoma (Cell Line: OVCAR3) [4]
Raloxifene + Anastrozole DCWOJIR Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [4]
Raloxifene + Anastrozole DCWTQZX Raloxifene Melanoma (Cell Line: UACC-257) [4]
Raloxifene + Anastrozole DCIZC6T Raloxifene Melanoma (Cell Line: SK-MEL-2) [4]
Raloxifene + Anastrozole DC4IX9A Raloxifene Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Ruxolitinib + Anastrozole DCENKG7 Ruxolitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Ruxolitinib + Anastrozole DCRL59M Ruxolitinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Ruxolitinib + Anastrozole DC7Z4DT Ruxolitinib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Vandetanib + Anastrozole DC9SKDB Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [5]
Vandetanib + Anastrozole DCLMO9T Vandetanib Carcinoma (Cell Line: MCF7) [5]
Vandetanib + Anastrozole DCAQ05L Vandetanib Anaplastic large cell lymphoma (Cell Line: SR) [4]
Vandetanib + Anastrozole DCI9VH3 Vandetanib Astrocytoma (Cell Line: SNB-19) [4]
Vandetanib + Anastrozole DCWI4UN Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Vandetanib + Anastrozole DC93IKC Vandetanib Glioma (Cell Line: SF-295) [4]
Vandetanib + Anastrozole DCWCMHA Vandetanib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Vandetanib + Anastrozole DCC2EL3 Vandetanib Prostate carcinoma (Cell Line: PC-3) [4]
Vandetanib + Anastrozole DC7O41R Vandetanib Renal cell carcinoma (Cell Line: SN12C) [4]
Vemurafenib + Anastrozole DCLTIER Vemurafenib Colon adenocarcinoma (Cell Line: COLO 205) [5]
Vemurafenib + Anastrozole DC6BIYS Vemurafenib Amelanotic melanoma (Cell Line: M14) [4]
Vemurafenib + Anastrozole DCI51X2 Vemurafenib Amelanotic melanoma (Cell Line: MDA-MB-435) [4]
Vemurafenib + Anastrozole DCTB00B Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [4]
Vemurafenib + Anastrozole DCD00EV Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [4]
Vemurafenib + Anastrozole DCJXIE1 Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [4]
Vemurafenib + Anastrozole DCDOCGY Vemurafenib Non-small cell lung carcinoma (Cell Line: HOP-92) [4]
Vemurafenib + Anastrozole DCJ146O Vemurafenib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Vismodegib + Anastrozole DC4RHTW Vismodegib Carcinoma (Cell Line: MCF7) [5]
Vismodegib + Anastrozole DCXKG8Z Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Vismodegib + Anastrozole DCSX8GQ Vismodegib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [4]
Vismodegib + Anastrozole DCLSJHG Vismodegib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [4]
Vismodegib + Anastrozole DCK3AHF Vismodegib Prostate carcinoma (Cell Line: PC-3) [4]
Vismodegib + Anastrozole DC7IK88 Vismodegib Renal cell carcinoma (Cell Line: UO-31) [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 1082 DrugCom(s)
28 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Anastrozole + Saracatinib DC3E1BS Saracatinib Breast Cancer [6]
Anastrozole + Estradiol DC4R260 Estradiol Breast Cancer [7]
Anastrozole + Bicalutamide DCJJT6T Bicalutamide Puberty, Precocious [8]
Anastrozole + Vandetanib DCSZ9D8 Vandetanib Breast Cancer [9]
Enzalutamide + Anastrozole DCWQ4LW Enzalutamide Breast Cancer [10]
Erlotinib + Anastrozole DCPTGI4 Erlotinib Solid Tumors [11]
Everolimus + Anastrozole DCLQUUS Everolimus Solid Tumors [11]
Fulvestrant + Anastrozole DC3MS0U Fulvestrant Breast Cancer [12]
Gefitinib + Anastrozole DCQPDOM Gefitinib Estrogen Receptor-positive Breast Cancer [13]
Goserelin + Anastrozole DCLJVYT Goserelin Breast Cancer [14]
Letrozole + Anastrozole DC9ZJJD Letrozole Breast Cancer [15]
Leuprolide + Anastrozole DCZVOGR Leuprolide Hypertension [16]
Lonafarnib + Anastrozole DCVMQMU Lonafarnib Breast Cancer [17]
LY2835219 + Anastrozole DCAP4QX LY2835219 Breast Neoplasms [18]
Olaparib + Anastrozole DC4U7EG Olaparib Solid Tumours [19]
Risedronate + Anastrozole DC1T71L Risedronate Breast Cancer [20]
Simvastatin + Anastrozole DC2G07J Simvastatin Breast Cancer [21]
SNDX-275 + Anastrozole DCDIM5L SNDX-275 Estrogen Receptor-negative Breast Cancer [22]
Tamoxifen + Anastrozole DCAIMGY Tamoxifen Bone Density [23]
Tamoxifen + Anastrozole DCUKPRA Tamoxifen Quality of Life [24]
Testosterone + Anastrozole DCVOA4Q Testosterone Aging [25]
Zoledronate + Anastrozole DCFSGGI Zoledronate Breast Cancer [26]
Anastrozole + Triptorelin DC4AK7R Triptorelin Breast Cancer [27]
Degarelix + Anastrozole DCPYA1K Degarelix Male Breast Cancer [28]
Letrozole + Anastrozole DCF5OEQ Letrozole Breast Cancer [29]
Letrozole + Anastrozole DCDFSM5 Letrozole Anatomic Stage I Breast Cancer AJCC v8 [30]
LY2835219 + Anastrozole DC24QBY LY2835219 Breast Cancer [31]
Letrozole + Anastrozole DCU90CT Letrozole Breast Cancer [32]
------------------------------------------------------------------------------------
⏷ Show the Full List of 28 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5137).
2 Anastrozole FDA Label
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
5 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
6 ClinicalTrials.gov (NCT01216176) A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
7 ClinicalTrials.gov (NCT00661531) Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
8 ClinicalTrials.gov (NCT00094328) Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
9 ClinicalTrials.gov (NCT00481845) Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
10 ClinicalTrials.gov (NCT01597193) Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
11 ClinicalTrials.gov (NCT01197170) Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
12 ClinicalTrials.gov (NCT00075764) S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
13 ClinicalTrials.gov (NCT00057941) Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
14 ClinicalTrials.gov (NCT00186121) Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
15 ClinicalTrials.gov (NCT00681928) Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy
16 ClinicalTrials.gov (NCT01763541) Study of the Effect of Testosterone and Estradiol on NP Responses to Acute and Chronic Salt Loading
17 ClinicalTrials.gov (NCT00081510) Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)
18 ClinicalTrials.gov (NCT02057133) A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
19 ClinicalTrials.gov (NCT02093351) To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer
20 ClinicalTrials.gov (NCT00082277) Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer
21 ClinicalTrials.gov (NCT00354640) Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer
22 ClinicalTrials.gov (NCT01234532) Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery
23 ClinicalTrials.gov (NCT00784940) ATAC - Bone Density Sub-Protocol
24 ClinicalTrials.gov (NCT00784680) ATAC - Quality of Life Sub-Protocol
25 ClinicalTrials.gov (NCT00309855) Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men
26 ClinicalTrials.gov (NCT00295646) Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
27 ClinicalTrials.gov (NCT05896566) A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer
28 ClinicalTrials.gov (NCT05501704) ETHAN - ET for Male BC
29 ClinicalTrials.gov (NCT02585388) Addition of Aromatase at the Navelbine in Pretreated Metastatic Breast Cancer.
30 ClinicalTrials.gov (NCT04294225) Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer
31 ClinicalTrials.gov (NCT02441946) A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer
32 ClinicalTrials.gov (NCT02730091) A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease